CClinicalTrials.gg
Status unknownNCT02605889ACT-DMUpdated Nov 16, 2015

Acupuncture in the Complementary Treatment of Diabetes Mellitus Type II

An interventional study of Laser acupuncture in Diabetes Mellitus, sponsored by NEIDE APARECIDA TITONELLI ALVIM. Status unknown at 1 site in Brazil. Open to participants aged 30 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-11-16.

Sponsored by NEIDE APARECIDA TITONELLI ALVIM · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2015), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
30 Years to 75 Years
Sex
All
01

Study summary

This is a randomized clinical research, with triple blinded multicenter involving the Federal University of Rio de Janeiro, through the School of Nursing Anna Nery, as a proponent and research coordinator; and as a collaborative educational institutions, the Federal University of Espirito Santo, represented by the Department of Nursing; and the Higher School of Sciences of the Santa Casa de Misericordia de Vitoria, through the Master's Programme in Public Policy and Local Development.

As Research, the study covers health units of the Municipal Family Health Maricá / Rio de Janeiro, the Municipal Victoria Health / Holy Spirit, beyond the scope of Integrated Project Research-Service (PIPA), linked to Nursing Anna Nery / Federal University of Rio de Janeiro.

The object of investigation is the effectiveness of acupuncture in nursing care in complementary treatment of adult patients Diabetes Mellitus type II.

Read the detailed description

This study has the general objective to evaluate the effectiveness of acupuncture as a complementary treatment to medication used in patients with diabetes mellitus type II, based on the nursing diagnoses.

02

Conditions studied

  • Diabetes Mellitus

Browse trials for

03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's planned enrollment of 132 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

This is the only study on the registry with NEIDE APARECIDA TITONELLI ALVIM as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Be in possession of Diabetes Mellitus Type II only
  • It is undergoing treatment for at least 1 year properly prescribed (to be confirmed with the medication of revenue)
  • Report difficulties in glycemic control, regular saving measures higher than recommended by the Brazilian Society of Diabetes (postprandial up to 180mg / dl)

Exclusion criteria

Exclusion Criteria:

  • Have a lower limb amputated or part of them (because of the location of the selected acupoints for the treatment protocol)
  • Be insulin
  • Being a smoker
  • Be alcoholic
  • Be in drug treatment for other diseases including obesity
  • Be making specific diet for weight loss
  • Practicing regular physical activity
  • Be in possession of cancer
  • Being pregnant
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
132 participants (estimated)

Study arms

  • Experimental
    Group A

    Laser acupuncture

    Other: Laser acupuncture

  • Sham comparator
    Group B

    Simulation Laser acupuncture

    Other: Laser acupuncture

Interventions

  • OtherLaser acupuncture

    Laser acupuncture

06

What researchers measure

Primary outcomes

  1. Improvement of blood postprandial glucose levels

    Time frame: six week

Secondary outcomes

  1. Improvement of Nursing Diagnoses

    Time frame: six week

07

Study locations

1 of 1 sites recruiting
  • Claudia Dayube Pereira
    Rio de Janeiro, 24900000, Brazil
    • Claudia d pereira · Contact · 552198587536257
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 16, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02605889
Lead sponsor
NEIDE APARECIDA TITONELLI ALVIM
Responsible party
NEIDE APARECIDA TITONELLI ALVIM (Phd Nursing, Universidade Federal do Rio de Janeiro) — Sponsor-investigator
First posted
Nov 16, 2015
Start date
Oct 2014
Primary completion
Dec 2015 (estimated)
Completion
Jan 2016 (estimated)
Last update
Nov 16, 2015

Study contacts

CLAUDIA Pereira, student
Contact
cdayube@hotmail.com
21985876257
Neide Alvim, PhD
principal investigator · Universidade Federal do Rio de Janeiro

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion